Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors

This study has been completed.
Sponsor:
Information provided by:
Biogen
ClinicalTrials.gov Identifier:
NCT00618735
First received: February 8, 2008
Last updated: June 7, 2012
Last verified: January 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)